Supramolecular architecture, thermal, Quantum chemical analysis and in vitro biological properties on sulfate salt of 4-aminoantipyrine

Synthesis, characterization, DFT studies and evaluation of the potential anti-tumour activity of nicotinic hydrazide based Schiff base using in vitro and molecular docking techniques

Breast cancer, one of the most serious issues worldwide, has been raising day by day. It has now become a necessary to develop a suitable drug to combat this terrible illness. Schiff bases are increasingly being used as powerful medications for a number of illnesses. BNH has now synthesized from Benzil and Nicotinic hydrazide and characterized experimentally by FT-IR, UV, 1H NMR,13CNMR and Mass analysis. DFT calculations were done using Gaussian 16 W with B3LYP/6-311 + G (d,p) and geometry of the compound is optimized. Frontier Molecular orbit (FMO), Mullikan atomic charges and Molecular Electrostatic Potential (MEP) were studied. Invitro antimicrobial studies were done using various bacteria and fungi. The synthesized compound is appropriate against bacterial and fungal actions. Invitro study were done using MCF-7 cell lines to analyze the anticancer property of the ligand. The outcome suggests that BNH may be employed in the future as a novel anticancer medication.

Study of the Crystal Architecture, Optoelectronic Characteristics, and Nonlinear Optical Properties of 4-Amino Antipyrine Schiff Bases

Two Schiff bases, (E)-4-((2-chlorobenzylidene)amino)-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one (4AAPOCB) and (E)-4-((4-chlorobenzylidene)amino)-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one (4AAPPCB), have been synthesized and grown as single crystals. Single-crystal X-ray diffraction analysis was employed to determine the crystal structure of the compounds, and the results suggest that the compounds crystallized into an orthorhombic crystal system having P2₁2₁2₁ and Pbca space groups, respectively. Further, the crystallinity of the compounds was analyzed by the PXRD technique. The UV-vis-NIR spectra of the compounds demonstrate excellent transmittance in the entire visible region. The lower cutoff wavelengths of the compounds were determined to be 338 and 333 nm, respectively; additionally, optical band gaps of the compounds found were 4.60 and 4.35 eV. FTIR and NMR (¹H and ¹³C) spectral techniques were utilized to analyze the molecular structure of the compounds. The compounds emit photoluminescence with broad emission bands with centers at 401 and 418 nm. The thermal stability and phase transitions were assessed through thermogravimetric methods. The phase transition prior to melting was indicated by the endothermic event at around 190 °C in the DTA curves of both crystals, and the same was observed in the DSC curves. The second harmonic efficiencies of the powdered compounds I and II were found to be 3.52 and 1.13 times better than that of the standard reference KDP. The 4AAPOCB and 4AAPPCB compounds showed isotropic polarizability amplitudes of 46.02 × 10^-24 and 46.52 × 10^-24 esu, respectively. The calculation of linear polarizability and NLO second-order polarizability (β) along with other optical parameters was performed for optimized geometries. The nonzero amplitudes of the average β values for compounds 4AAPOCB and 4AAPPCB were found to be 14.74 × 10^-30 and 8.10 × 10^-30 esu, respectively, which show a decent potential of the synthesized molecules for NLO applications. The calculated β amplitudes were further explained based on calculated electronic parameters like molecular electrostatic potentials, frontier molecular orbitals, molecular orbital energies, transition energies, oscillator strengths, and unit spherical representation of NLO polarizability. The current analysis emphasizes the significance of synthesized compounds as prospective candidates for optical and NLO applications through the use of experiments and quantum computations.

Synthesis, crystal structure, potential drug properties for Coronavirus of Co(II) and Zn(II) 2-chlorobenzoate with 3-cyanopyridine complexes

Two new complexes of Co(II) and Zn(II) 2-chlorobenzoate (2-ClBA) with 3-cyanopyridine (CNP) of the general formula [Co(2-ClBA)₂(CNP)₂(H₂O)₂] and [Zn(2-ClBA)₂(CNP)₂(H₂O)₂] were synthesized. The structures of the complexes were characterized by single crystal XRD and FT-IR and NMR spectroscopy and Mass Spectrometry (MALDI-TOF MS) methods. Mononuclear complexes exhibit octahedral coordination. In addition, Hirshfeld surface analysis was performed to determine non-covalent interactions in crystal packing. The geometry optimization of the molecules was carried out using the LANL2DZ level of theory of the DFT method and the obtained findings were confirmed by comparing with the data obtained from the single crystal X-ray diffraction method. The theoretical and experimental bond angles and lengths are very close to each other. The effectiveness of the complexes against SARS-CoV-2 enzymes was investigated in silico using the molecular docking method, and a binding score of -8.0 kcal/mol on NSP16 of complex 1 as an inhibitor was obtained. To investigate the drug potential of the complexes, their pharmacokinetic and toxicokinetic properties were estimated by ADMET calculations.